Announcements

Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




Canada: Canopy Growth funds AIDS research project

The Canadian AIDS Society announced a first of its kind research program funded by Canopy Growth Corporation. The program is designed to provide up-to-date information on the current state of evidence and research pertaining to the use of cannabis for medical purposes and to build tools for healthcare professionals to allow them to confidently assess and prescribe cannabis to appropriate patients.

Funded over two years at $100,000 per year by Canopy Growth Corporation — and guided by a newly created Cannabis Research Task Force of experts in the field of cannabinoid medicine — the project aims to develop guidelines and recommendations regarding the medical use of cannabis for optimal wellness, quality of life and pain management.

“Our goal is to leverage our existing knowledge and expertise in both HIV and the use of cannabis for medical purposes to create a better quality of life for many Canadians facing debilitating health conditions — particularly in the area of chronic pain management,” said Gary Lacasse, Executive Director of the Canadian AIDS Society. “This project builds on a body of existing knowledge and research developed by CAS over several years.”

The Task Force will be addressing issues surrounding the current lack of information — for Canadian health care practitioners and ultimately for patients — regarding guidance on the use of cannabis for medical or therapeutic purposes. It is estimated that 10% of Canadian physicians have written an authorization for medical cannabis.

“We are confident that this partnership with the Canadian AIDS Society and the broad medical and social expertise of the Task Force will result in practical guidelines for the use of cannabis that can be applied to many medical conditions,” said Mark Zekulin, President, Canopy Growth Corporation. “We have dedicated a great deal of effort into physician education over the last three years and I feel confident that this work will create another valuable tool that Canadian healthcare professionals and Canadians alike can use when considering cannabis as a therapy..”

The Cannabis Research Task Force is expected to review the current state of research for the use of medical cannabis and develop a scope of work for evidence-based Canadian guidelines in such areas as treatment, contraindications, dosing, chronic pain, risk management and regulatory issues, among others.

For more information:
www.cdnaids.ca
www.canopygrowth.com

Publication date: 7/7/2017

 


 

Other news in this sector:

7/21/2017 Canada’s premiers discuss delaying MJ legalization
7/21/2017 Australia: The Hydroponics Company granted cannabis research licence
7/21/2017 US: Puration acquires 25-greenhouse grow operation
7/20/2017 Canadian firm invests in African MMJ cultivation
7/20/2017 CAN (BC): Nicolas Elbaze joins Sublime team
7/20/2017 US (CO): Grower optimizes cannabis operation for hot climate
7/20/2017 US (CA): Do's and don'ts of cannabis and crop protection
7/19/2017 US (WA): MCOA receives funding for 30,000 sq. ft. greenhouse
7/19/2017 Uruguay legalizes over-the-counter cannabis sales
7/18/2017 US states say 'yes' to MMJ, federal govt says 'no'
7/18/2017 US: Hawaii's MMJ industry not getting off the ground
7/17/2017 Australia: Victorian minister finds MMJ inspiration in Canada and Israel
7/14/2017 Greece legalises marijuana for medical purposes
7/14/2017 Puerto Rico enacts medicinal marijuana law
7/14/2017 US (AR): No applications yet for MMJ cultivation
7/13/2017 US (NV): Two more recreational MJ licenses for Marapharm
7/13/2017 CAN (ON): Former rose farm becomes MMJ operation
7/13/2017 CAN (ON): Police monitoring marijuana grow-op at former flowers greenhouse
7/12/2017 US (AZ): Merger creates large Arizona MMJ farm
7/11/2017 US (NV): 'State of emergency' due to marijuana shortage